Guidant Wealth Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$189K Sell
1,461
-10
-0.7% -$1.32K 0.07% 108
2019
Q2
$205K Buy
1,471
+6
+0.4% +$831 0.08% 106
2019
Q1
$205K Buy
1,465
+950
+184% +$127K 0.08% 106
2018
Q4
$66K Sell
515
-8
-2% -$1.12K 0.03% 113
2018
Q3
$73K Buy
523
+8
+2% +$1.06K 0.03% 69
2018
Q2
$62K Sell
515
-31
-6% -$3.87K 0.03% 70
2018
Q1
$68K Buy
546
+31
+6% +$4.19K 0.03% 68
2017
Q4
$73K Sell
515
-219
-30% -$30.5K 0.03% 69
2017
Q3
$97K Hold
734
0.07% 55
2017
Q2
$96K Buy
734
+219
+43% +$27.9K 0.05% 85
2017
Q1
$64K Buy
515
+315
+158% +$37.6K 0.03% 103
2016
Q4
$23K Hold
200
0.01% 120
2016
Q3
$24K Buy
+200
New +$24.3K 0.01% 115

Other funds holding JNJ

Guidant Wealth Advisors's JNJ Position: Q3 2019 in Review

Guidant Wealth Advisors reduced its Johnson & Johnson (JNJ) stake by 0.68% in Q3 2019, selling an estimated $1.32K and leaving 1,461 shares worth $189K. The position accounts for 0.07% of the portfolio, ranked #108.

Guidant Wealth Advisors first reported a position in JNJ in Q3 2016 and has held it in 13 quarters since. The position peaked at $205K in Q2 2019. 2,724 funds tracked by Wall St. Rank hold JNJ as of Q3 2019.

  • Guidant Wealth Advisors held 1,461 shares of Johnson & Johnson worth $189K as of Q3 2019.
  • Guidant Wealth Advisors sold 10 Johnson & Johnson shares in Q3 2019, an estimated $1.32K.
  • Johnson & Johnson made up 0.07% of Guidant Wealth Advisors's portfolio in Q3 2019, its #108 holding.
  • Guidant Wealth Advisors first reported a position in Johnson & Johnson in Q3 2016 and has held it in 13 quarters since.
  • Guidant Wealth Advisors's Johnson & Johnson position peaked at $205K in Q2 2019.
  • 2,724 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2019.

Based on Guidant Wealth Advisors's 13F filing for Q3 2019, filed 16 Oct 2019.